[go: up one dir, main page]

CN102409068A - A kind of preparation method of (3aS,6aR)-biotin chiral lactone - Google Patents

A kind of preparation method of (3aS,6aR)-biotin chiral lactone Download PDF

Info

Publication number
CN102409068A
CN102409068A CN2011103704667A CN201110370466A CN102409068A CN 102409068 A CN102409068 A CN 102409068A CN 2011103704667 A CN2011103704667 A CN 2011103704667A CN 201110370466 A CN201110370466 A CN 201110370466A CN 102409068 A CN102409068 A CN 102409068A
Authority
CN
China
Prior art keywords
lactone
esterase
microbacterium
preparation
methyl esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2011103704667A
Other languages
Chinese (zh)
Other versions
CN102409068B (en
Inventor
徐毅
吴范宏
朱勇刚
于凤娟
陈建波
周音卉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZHEJIANG SHENGDA BIO-PHARM Co Ltd
Shanghai Institute of Technology
Original Assignee
ZHEJIANG SHENGDA PHARMACEUTICAL CO LTD
Shanghai Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZHEJIANG SHENGDA PHARMACEUTICAL CO LTD, Shanghai Institute of Technology filed Critical ZHEJIANG SHENGDA PHARMACEUTICAL CO LTD
Priority to CN201110370466.7A priority Critical patent/CN102409068B/en
Publication of CN102409068A publication Critical patent/CN102409068A/en
Application granted granted Critical
Publication of CN102409068B publication Critical patent/CN102409068B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

本发明公开了一种(3aS,6aR)-生物素手性内酯的制备方法,其特征在于采用巧克力微杆菌(Microbacteriumchocolatum)SIT101CGMCCNO.4436发酵生产酯酶,然后以内消旋二甲酯为该酶转化的底物,酶转化反应液中的产物经酸化、溶剂萃取、浓缩、干燥后得(4S,5R)-半甲酯再与还原剂硼氢化钠或硼氢化钾在无水乙醇中进行还原反应18-30h,所得还原产物经内酯化、沉淀和干燥后最终得到(3aS,6aR)-生物素手性内酯。本发明的制备方法具有反应条件温和、催化效率高、最终产物收率高及生产成本低的特点,同时具有较低的能量消耗、物料消耗和三废产出,适于大规模的生产。

Figure 201110370466

The invention discloses a method for preparing a (3a S , 6a R )-biotin chiral lactone, which is characterized in that esterase is produced by fermentation with Microbacteriumchocolatum SIT101CGMCCNO.4436, and then meso-dimethyl ester is used as a substrate for the enzyme conversion. The product in the enzyme conversion reaction liquid is acidified, solvent extracted, concentrated, and dried to obtain (4 S , 5 R )-semimethyl ester, which is then subjected to reduction reaction with a reducing agent, sodium borohydride or potassium borohydride, in anhydrous ethanol for 18-30 hours. The obtained reduction product is lactonized, precipitated, and dried to finally obtain (3a S , 6a R )-biotin chiral lactone. The preparation method of the invention has the characteristics of mild reaction conditions, high catalytic efficiency, high final product yield, and low production cost, and at the same time has low energy consumption, material consumption, and three wastes output, and is suitable for large-scale production.

Figure 201110370466

Description

一种(3aS,6aR)-生物素手性内酯的制备方法A kind of preparation method of (3aS,6aR)-biotin chiral lactone

技术领域 technical field

本发明涉及一种(3aS,6aR)-生物素手性内酯的制备方法,特别涉及一种利用利用巧克力微杆菌(Microbacterium chocolatum) SIT101 CGMCC NO.4436 进行发酵产酶,并进行酶催化内消旋二酯的不对称水解制备(4S,5R)-半甲酯,半甲酯经还原剂还原、内酯化得到(3aS, 6aR)-生物素手性内酯的方法。  The present invention relates to a preparation method of (3a S ,6a R )-biotin chiral lactone, in particular to a method for producing enzyme by fermentation using Microbacterium chocolatum SIT101 CGMCC NO.4436, and performing enzyme-catalyzed internal Asymmetric hydrolysis of racemic diester to prepare (4 S ,5 R )-hemimethyl ester, and hemimethyl ester is reduced by reducing agent and lactonized to obtain (3a S , 6a R )-biotin chiral lactone.

背景技术 Background technique

已知如式(I)所示的(3aS, 6aR)-生物素手性内酯是合成d-生物素(d-Biotin,又名维生素H和辅酶R)的关键手性中间体,其结构式(I)如下所示:  It is known that (3a S , 6a R )-biotin chiral lactone shown in formula (I) is a key chiral intermediate for the synthesis of d -biotin ( d -Biotin, also known as vitamin H and coenzyme R), which Structural formula (I) is as follows:

Figure 2011103704667100002DEST_PATH_IMAGE001
Figure 2011103704667100002DEST_PATH_IMAGE001

d-生物素又名维生素H,是水溶性B簇维生素之一。它是羧化酶的辅酶,也是糖、蛋白质和脂肪中间代谢中的一个重要辅酶。除了一部分细菌,酵母和植物能自身合成生物素外,几乎所有的动物和一部分微生物都要从外源获得生物素。生物素用途广泛,20-30%用于医用原料,50%用于饲料,另外还用作化妆品原料、营养添加剂等。 d -Biotin, also known as vitamin H, is one of the water-soluble B vitamins. It is a coenzyme of carboxylase and an important coenzyme in the intermediate metabolism of sugar, protein and fat. Except some bacteria, yeast and plants can synthesize biotin by themselves, almost all animals and some microorganisms need to obtain biotin from exogenous sources. Biotin has a wide range of uses, 20-30% is used for medical raw materials, 50% is used for feed, and it is also used as cosmetic raw materials and nutritional additives.

已报道的(3aS,6aR)-生物素手性内酯合成方法主要有拆分法、不对称合成和生物合成。  The reported synthesis methods of (3a S ,6a R )-biotin chiral lactone mainly include resolution method, asymmetric synthesis and biosynthesis.

化学方法拆分,如利用光学活性薄荷醇或手性胺麻黄碱拆分前体物质,再转化得到右旋生物素中间体内酯。化学拆分法的缺点是拆分剂价格昂贵,分离不完全,还有环境污染和毒性问题。物理方法拆分,如用诱导结晶拆分前体半甲酯,再还原得到右旋生物素中间体内酯,条件控制要求高,光学纯度差,收率低。  Chemical resolution, such as using optically active menthol or chiral amine ephedrine to resolve precursor substances, and then converting to obtain D-biotin intermediate lactone. The disadvantages of the chemical resolution method are that the resolution agent is expensive, the separation is not complete, and there are environmental pollution and toxicity problems. Physical separation, such as the use of induced crystallization to resolve the precursor hemimethyl ester, and then reduction to obtain the D-biotin intermediate lactone, requires high condition control, poor optical purity, and low yield. the

目前工业上主要采取还原不对称环酰亚胺的方法来制备(3aS,6aR)-生物素手性内酯(Tetrahedron. Lett., 1999, 40, 8873-8876.)。在合成过程中引入与底物相同摩尔当量的手性胺与二酸底物形成手性环酰亚胺,再经化学还原、内酯化关环得到生物素手性内酯。该方法因为引入了昂贵的手性胺,成本较高,三废处理较为复杂。  At present, the industry mainly adopts the method of reducing asymmetric cyclic imide to prepare (3a S ,6a R )-biotin chiral lactone (Tetrahedron. Lett., 1999, 40, 8873-8876.). During the synthesis process, a chiral amine with the same molar equivalent as the substrate is introduced to form a chiral cyclic imide with a diacid substrate, and then undergoes chemical reduction and lactonization ring closure to obtain a biotin chiral lactone. Because the method introduces expensive chiral amines, the cost is high, and the treatment of the three wastes is relatively complicated.

近年来,也有文献报道了生物催化制备的方法。例如日本学者(Agric. Biol Chem.,1982, 46(7), 1907)用猪肝酯酶不对称水解前手性二丙酯得到光学活性单酯,再经硼氢化锂还原得到右旋生物素中间体内酯,产率为85%,ee值为75%。陈芬儿等(Adv.Synth.Catal.2005,347,549)用固定化猪肝酯酶催化前手性二甲酯水解,产物手性半甲酯(ee值为91%)经重结晶、化学还原内酯化后得到手性内酯,产率约为60%。利用酯酶催化不对称水解内消旋二酯的方法理论上可以以100%的产率得到光学纯的单酯产物,克服了传统动力学拆分50%的理论局限性,而且避免了传统拆分剩余底物需要化学消旋的弊端。与化学还原不对称环酰亚胺的方法比,不需要引入手性胺,因此将有效的减小生产物料的成本和生产废水中有机物的含量,结合酶催化特有的反应条件温和、选择性高、能耗小等优点,是很有希望的取代现有化学工艺的新方法。目前存在的主要问题是猪肝酯酶的选择性不够高,得到的半甲酯需要重结晶后才能进行化学还原,这样导致手性内酯的收率偏低,仅为60%左右,并且猪肝酯酶价格昂贵,其动物来源限制了催化剂的大规模获得与使用,从而限制了(3aS,6aR)-生物素手性内酯的大规模生产。  In recent years, there are also literatures reporting the method of biocatalytic preparation. For example, Japanese scholars (Agric. Biol Chem., 1982, 46(7), 1907) used pig liver esterase to asymmetrically hydrolyze prochiral dipropyl ester to obtain optically active monoester, and then reduced it with lithium borohydride to obtain D-biotin Intermediate lactone, the yield is 85%, and the ee value is 75%. Chen Fen'er et al. (Adv.Synth.Catal.2005,347,549) used immobilized porcine liver esterase to catalyze the hydrolysis of prochiral dimethyl esters, and the product chiral hemimethyl esters (ee value 91%) were recrystallized and chemically reduced The chiral lactone is obtained after lactonization, and the yield is about 60%. The method of using esterase to catalyze the asymmetric hydrolysis of meso diester can theoretically obtain optically pure monoester products with 100% yield, which overcomes the theoretical limitation of 50% of traditional kinetic resolution and avoids the traditional resolution. Disadvantages of chemical racemization are required to divide the remaining substrate. Compared with the method of chemical reduction of asymmetric cyclic imide, there is no need to introduce chiral amine, so it will effectively reduce the cost of production materials and the content of organic matter in production wastewater, combined with the mild reaction conditions and high selectivity unique to enzyme catalysis , low energy consumption and other advantages, is a promising new method to replace the existing chemical process. The main problem existing at present is that the selectivity of pig liver esterase is not high enough, and the obtained hemimethyl ester needs to be recrystallized before it can be chemically reduced, which leads to a low yield of chiral lactone, only about 60%, and pig liver Liver esterase is expensive, and its animal origin limits the large-scale acquisition and use of catalysts, thereby limiting the large-scale production of (3a S ,6a R )-biotin chiral lactone.

发明内容 Contents of the invention

本发明的目的在于为了解决上述技术问题而提供一种(3aS,6aR)-生物素手性内酯的制备方法,即将巧克力微杆菌(Microbacterium chocolatum) SIT101 CGMCC NO.4436作为生物催化剂高选择性地催化内消旋二甲酯(III)不对称水解产生(4S,5R)-半甲酯(II),所得(4S,5R)-半甲酯(II)经化学还原、内酯化合成为(3aS,6aR)-生物素手性内酯(I)。  The purpose of the present invention is to provide a preparation method of (3a S ,6a R )-biotin chiral lactone in order to solve the above technical problems, that is to use Microbacterium chocolate SIT101 CGMCC NO.4436 as a biocatalyst with high selectivity Catalyzed asymmetric hydrolysis of meso dimethyl ester (III) to produce (4 S ,5 R )-hemimethyl ester (II), the obtained (4 S ,5 R )-hemimethyl ester (II) was chemically reduced, internally Esterification into (3a S ,6a R )-biotin chiral lactone (I).

其中(4S,5R)-半甲酯(II)的结构式如下:  Wherein the structural formula of (4 S ,5 R )-hemimethyl ester (II) is as follows:

Figure 266945DEST_PATH_IMAGE002
Figure 266945DEST_PATH_IMAGE002

内消旋二甲酯(III)的结构式如下: The structural formula of meso dimethyl ester (III) is as follows:

Figure 2011103704667100002DEST_PATH_IMAGE003
Figure 2011103704667100002DEST_PATH_IMAGE003
.

本发明采用的技术方案  The technical scheme adopted in the present invention

一种(3aS,6aR)-生物素手性内酯的制备方法,即采用高产酯酶的巧克力微杆菌(Microbacterium chocolatum) SIT101 CGMCC NO.4436(该菌株已于2010年12月8日保藏于中国微生物菌种保藏管理委员会普通微生物中心)发酵生产酯酶,然后以内消旋二甲酯为该酯酶转化的底物,酯酶转化反应液中的产物经酸化、溶剂萃取、浓缩、干燥后得(4S,5R)-半甲酯(II),(4S,5R)-半甲酯(II)再与还原剂硼氢化钠或硼氢化钾在无水乙醇中进行还原反应18-30h,所得还原产物经内酯化、沉淀和干燥后最终得到高光学纯度的(3aS,6aR)-生物素手性内酯(I)。 A method for preparing (3aS, 6aR)-biotin chiral lactone, namely using Microbacterium chocolatum SIT101 CGMCC NO.4436 with high esterase yield Strain Preservation Management Committee General Microbiology Center) to produce esterase by fermentation, and then use meso-dimethyl ester as the substrate for the esterase conversion, and the product in the esterase conversion reaction solution is acidified, solvent extracted, concentrated, and dried to obtain ( 4S,5R)-hemimethyl ester (II), (4S,5R)-hemimethyl ester (II) and reducing agent sodium borohydride or potassium borohydride in absolute ethanol for 18-30h, the resulting reduction product After lactonization, precipitation and drying, the (3aS,6aR)-biotin chiral lactone (I) with high optical purity was finally obtained.

附图说明 Description of drawings

上述的(3aS,6aR)-生物素手性内酯制备过程反应示意图如图1。  The reaction schematic diagram of the above (3a S ,6a R )-biotin chiral lactone preparation process is shown in Fig. 1 .

上述制备方法所得的(3aS,6aR)-生物素手性内酯的ee值为98.0%,熔点121.0-121.7℃,(C=1,氯仿)。  The (3a S ,6a R )-biotin chiral lactone obtained by the above preparation method has an ee value of 98.0% and a melting point of 121.0-121.7°C. (C=1, chloroform).

本发明的技术效果  Technical effect of the present invention

本发明的一种(3aS,6aR)-生物素手性内酯的制备方法,即通过微生物酶水解制造中间产物(4S,5R)-半甲酯,再与还原剂反应后经内酯化反应生成(3aS,6aR)-生物素手性内酯的方法,由于采用了高活性和选择性的微生物酯酶为催化剂,反应条件温和、催化效率高、半甲酯的光学纯度高,可以无需结晶,直接被还原剂还原,经内酯化后生成高光学纯度的(3aS, 6aR)-生物素手性内酯,同时具有较高的收率。因此具有比现有化学法更低的能量消耗、物料消耗和三废产出。 A preparation method of (3a S , 6a R )-biotin chiral lactone of the present invention, that is, the intermediate product (4 S , 5 R )-hemimethyl ester is produced by microbial enzyme hydrolysis, and then reacted with a reducing agent and then internally The method of esterification reaction to generate (3a S ,6a R )-biotin chiral lactone, due to the use of highly active and selective microbial esterase as a catalyst, the reaction conditions are mild, the catalytic efficiency is high, and the optical purity of hemimethyl ester is high , can be directly reduced by a reducing agent without crystallization, and (3a S , 6a R )-biotin chiral lactone with high optical purity can be generated after lactonization with a high yield. Therefore, it has lower energy consumption, material consumption and output of three wastes than the existing chemical method.

而且本发明的一种(3aS, 6aR)-生物素手性内酯的制备方法,无需添加任何手性拆分剂,进一步节约了成本。与采用猪肝酯酶制备(3aS, 6aR)-生物素手性内酯的方法比较,本发明的一种(3aS, 6aR)-生物素手性内酯制备方法具有生产成本低而选择性更高,可以以较低的成本大规模的生产,因此比猪肝酯酶的方法具有更高的应用价值。  Moreover, the preparation method of a (3a S , 6a R )-biotin chiral lactone of the present invention does not need to add any chiral resolving agent, which further saves the cost. Compared with the method of preparing (3a S , 6a R )-biotin chiral lactone by using pig liver esterase, the method for preparing (3a S , 6a R )-biotin chiral lactone of the present invention has the advantages of low production cost and can be selected Higher in nature and can be mass-produced at a lower cost, so it has higher application value than the pig liver esterase method.

图1、(3aS,6aR)-生物素手性内酯制备过程反应示意图。  Figure 1. Schematic diagram of the preparation process of (3a S ,6a R )-biotin chiral lactone.

具体实施方式 Detailed ways

下面通过实施例对本发明进一步详细描述,但并不限制本发明。  The present invention is described in further detail below by way of examples, but the present invention is not limited. the

本发明所用的试剂皆为分析纯或化学纯规格。  The reagents used in the present invention are all analytically pure or chemically pure. the

本发明用的内消旋二甲酯的制备方法:  The preparation method of the meso-dimethyl ester used in the present invention :

将内消旋的二酸(28.32g,0.08mol),无水甲醇(16.2mL,0.4mol),浓硫酸 (0.4mL,7.5mmol)和苯(65mL)在搅拌条件下加热回流6 h,减压除掉溶剂,剩余物加入水(40mL)和乙酸乙酯(40mL),有机相分层后,水相再用乙酸乙酯(10mL)萃取3次,合并乙酸乙酯相,分别用2M Na2CO3 (共3次,每次5ml)和水(共4次,每次5ml)洗涤。之后用无水硫酸钠干燥,减压除掉溶剂后得到内消旋二甲酯(III),收率为92%,纯度为99%。 The meso-diacid (28.32g, 0.08mol), anhydrous methanol (16.2mL, 0.4mol), concentrated sulfuric acid (0.4mL, 7.5mmol) and benzene (65mL) were heated to reflux for 6 h under stirring conditions, and The solvent was removed by pressure, and water (40mL) and ethyl acetate (40mL) were added to the residue. After the organic phase was separated, the aqueous phase was extracted three times with ethyl acetate (10mL). The ethyl acetate phases were combined and washed with 2M Na 2 CO 3 (3 times in total, 5ml each time) and water (4 times in total, 5ml each time) for washing. After drying with anhydrous sodium sulfate, the solvent was removed under reduced pressure to obtain meso-dimethyl ester (III), with a yield of 92% and a purity of 99%.

 SR半甲酯的检测方法:手性液相色谱(色谱柱为Chiralcel OJ-H色谱柱,流动相为正己烷:异丙醇:三氟乙酸=92:8:0.1,紫外检测波长220nm,流速0.5ml/min);  The detection method of SR hemimethyl ester : chiral liquid chromatography (the chromatographic column is Chiralcel OJ-H chromatographic column, the mobile phase is n-hexane:isopropanol:trifluoroacetic acid=92:8:0.1, the ultraviolet detection wavelength is 220nm, the flow rate 0.5ml/min);

(3aS,6aR)-内酯的检测方法:手性液相色谱(色谱柱为Chiralcel OD-H色谱柱,流动相为正己烷:异丙醇=80:20,紫外检测波长210nm,流速1.0ml/min); (3a S ,6a R )-lactone detection method: Chiral liquid chromatography (the chromatographic column is a Chiralcel OD-H chromatographic column, the mobile phase is n-hexane:isopropanol=80:20, the ultraviolet detection wavelength is 210nm, and the flow rate is 1.0ml/min);

(4S,5R)-半甲酯的收率以内消旋二甲酯为底物计算; The yield of (4 S ,5 R )-hemimethyl ester was calculated using meso-dimethyl ester as substrate;

(3aS, 6aR)-生物素手性内酯的收率以(4S,5R)-半甲酯为底物计算。 The yield of (3a S , 6a R )-biotin chiral lactone was calculated using (4 S ,5 R )-hemimethyl ester as substrate.

实施例1Example 1

一种(3aS,6aR)-生物素手性内酯的制备方法,包括如下制备步骤: A preparation method of (3a S , 6a R )-biotin chiral lactone, comprising the following preparation steps:

(1)、(4S,5R)-半甲酯(II)的制备 (1) Preparation of (4 S ,5 R )-hemimethyl ester (II)

①、菌种的斜面培养 ① Incline culture of strains

取冰箱4℃保存的巧克力微杆菌(Microbacterium chocolatum) SIT101 CGMCC NO.4436菌种,取出后接种到斜面培养基上,在30 oC下培养48 h,得巧克力微杆菌(Microbacterium chocolatum) SIT101斜面种子,并将其保存在4℃的冰箱中; Take the Microbacterium chocolatum SIT101 CGMCC NO.4436 strain stored in the refrigerator at 4°C, take it out, inoculate it on the slant medium, and cultivate it at 30 o C for 48 hours to obtain the slant seeds of Microbacterium chocolatum SIT101 , and store it in a refrigerator at 4°C;

所述的斜面培养基:葡萄糖15.0 g/L,酵母膏5.0 g/L,蛋白胨10.0 g/L,MgSO4 1g/L,琼脂15-20g/L,pH7.0; The slant medium: glucose 15.0 g/L, yeast extract 5.0 g/L, peptone 10.0 g/L, MgSO 4 1g/L, agar 15-20 g/L, pH7.0;

②、产酶发酵培养 ②, Enzyme production fermentation culture

取4oC保存的巧克力微杆菌(Microbacterium chocolatum) SIT101 CGMCC NO.4436斜面种子,挑取一环接种至装有50ml发酵培养基的250ml摇瓶中,在30℃下,160rpm振摇培养48h,以10000g离心约15min得到含酯酶的巧克力微杆菌(Microbacterium chocolatum) SIT101静息细胞; Take Microbacterium chocolatum SIT101 CGMCC NO.4436 slant seeds preserved at 4 o C, pick a loop and inoculate it into a 250ml shaker flask containing 50ml of fermentation medium, and culture it at 30°C with shaking at 160rpm for 48h. Centrifuge at 10,000 g for about 15 minutes to obtain resting cells of Microbacterium chocolatum SIT101 containing esterase;

所述的发酵培养基:葡萄糖15.0g/L,酵母膏5.0g/L,蛋白胨10.0g/L,MgSO4 1g/L,pH7.0; The fermentation medium: glucose 15.0g/L, yeast extract 5.0g/L, peptone 10.0g/L, MgSO 4 1g/L, pH7.0;

③、(4S,5R)-半甲酯(II)的制备 ③. Preparation of (4 S ,5 R )-hemimethyl ester (II)

取湿重为7g的步骤(2)所得的含酯酶的巧克力微杆菌(Microbacterium chocolatum) SIT101静息细胞,悬浮于95ml浓度为0.1M,pH8.0的磷酸钠盐缓冲溶液中,加入内消旋二甲酯7mmol,再加入5ml二甲基亚砜,反应混合物在30℃、160r/min的恒温摇床上振摇反应48h后,加入2mol/L盐酸调水相pH值到2.0,用乙酸乙酯萃取酸化液3次,每次乙酸乙酯的用量为30ml,合并有机相并用无水硫酸钠干燥,之后减压蒸干有机相得到(4S,5R)-半甲酯,其收率为88%,纯度为98%,ee值大于99%; Take the esterase-containing Microbacterium chocolatum ( Microbacterium chocolatum ) SIT101 resting cells obtained in step (2) with a wet weight of 7 g, suspend them in 95 ml of sodium phosphate buffer solution with a concentration of 0.1 M, pH 8.0, and add internal Spin 7 mmol of dimethyl ester, then add 5 ml of dimethyl sulfoxide, shake the reaction mixture on a constant temperature shaker at 30 °C and 160 r/min for 48 h, add 2 mol/L hydrochloric acid to adjust the pH value of the water phase to 2.0, and use ethyl acetate Ester extraction acidified liquid 3 times, the consumption of each ethyl acetate is 30ml, combine organic phase and dry with anhydrous sodium sulfate, then evaporate organic phase under reduced pressure to obtain (4 S , 5 R )-hemimethyl ester, its yield 88%, the purity is 98%, and the ee value is greater than 99%;

(2)、(3aS,6aR)-生物素手性内酯的制备 (2) Preparation of (3a S ,6a R )-biotin chiral lactone

取采用步骤(1)的方法制得的(4S,5R)-半甲酯0.78g(2mmol)、无水氯化钙0.22g(2mmol)溶解于10mL无水乙醇中,然后控制温度在0℃,加入0.23g(6mmol)硼氢化钠,加入完毕后撤去冰浴,室温下搅拌反应30h,升温至55~60℃,加入5%盐酸溶液6mL,反应30min,TLC监测反应进程,待底物完全反应后,加入10mL蒸馏水,再放在冰水浴中冷却,出现无色沉淀,经过滤干燥后,最终得(3aS,6aR)-生物素手性内酯0.52g,收率为89%,ee值为97.8%。 Dissolve 0.78g (2mmol) of ( 4S , 5R )-hemimethylester and 0.22g (2mmol) of anhydrous calcium chloride in 10mL of absolute ethanol, and then control the temperature at 0°C, add 0.23g (6mmol) sodium borohydride, remove the ice bath after the addition is complete, stir the reaction at room temperature for 30h, raise the temperature to 55~60°C, add 5% hydrochloric acid solution 6mL, react for 30min, TLC monitors the reaction process, and waits until the bottom After the product was completely reacted, 10 mL of distilled water was added, and then cooled in an ice-water bath, a colorless precipitate appeared, and after filtration and drying, 0.52 g of (3a S , 6a R )-biotin chiral lactone was finally obtained, with a yield of 89%. , ee value is 97.8%.

实施例2Example 2

一种(3aS,6aR)-生物素手性内酯的制备方法,包括如下制备步骤: A preparation method of (3a S , 6a R )-biotin chiral lactone, comprising the following preparation steps:

(1)、(4S,5R)-半甲酯(II)的制备,同实施例1; (1), the preparation of (4 S ,5 R )-hemimethyl ester (II), the same as in Example 1;

(2)、(3aS,6aR)-生物素手性内酯的制备 (2) Preparation of (3a S ,6a R )-biotin chiral lactone

取采用步骤(1)的方法制得的(4S,5R)-半甲酯7.8g(20mmol)、无水氯化钙2.22g(20mmol)溶解于100mL无水乙醇中,然后控制温度在0℃,加入3.2g(60mmol)硼氢化钾,加入完毕后撤去冰浴,室温下搅拌反应18h,升温至55~60℃,加入5%盐酸溶液60mL,反应30min,TLC监测反应进程,待底物完全反应后,加入100mL蒸馏水,再放在冰水浴中冷却,出现无色沉淀,经过滤干燥后,最终得(3aS,6aR)-生物素手性内酯5.3克,收率为91%,ee值为98.0%,熔点121.0-121.7℃,

Figure 815792DEST_PATH_IMAGE006
(C=1,氯仿)。 Take (4 S ,5 R )-hemimethyl ester 7.8g (20mmol) and anhydrous calcium chloride 2.22g (20mmol) prepared by the method of step (1) and dissolve them in 100mL absolute ethanol, then control the temperature at 0°C, add 3.2g (60mmol) potassium borohydride, remove the ice bath after the addition, stir and react at room temperature for 18h, heat up to 55~60°C, add 60mL of 5% hydrochloric acid solution, react for 30min, monitor the reaction progress by TLC, wait until the bottom After the product was completely reacted, 100 mL of distilled water was added, and then cooled in an ice-water bath, a colorless precipitate appeared, and after filtration and drying, 5.3 grams of (3a S , 6a R )-biotin chiral lactone was finally obtained, with a yield of 91%. , ee value is 98.0%, melting point is 121.0-121.7℃,
Figure 815792DEST_PATH_IMAGE006
(C=1, chloroform).

以上所述内容仅为本发明构思下的基本说明,而依据本发明的技术方案所作的任何等效变换,均应属于本发明的保护范围。  The above content is only a basic description of the concept of the present invention, and any equivalent transformation made according to the technical solution of the present invention shall fall within the scope of protection of the present invention. the

Claims (7)

1. microbial enzyme manufactured (3a S, 6a RThe method of)-lactone is characterized in that comprising the steps:
(1), the production of esterase
Adopt chocolate microbacterium ( Microbacterium chocolatum) SIT101 CGMCC NO.4436 fermentative prodn esterase;
(2), intermediate product (4 S, 5 RThe preparation of)-half methyl esters
With the meso dimethyl ester is the substrate that the esterase of step (1) gained transforms, the product in the esterase conversion reaction liquid through acidifying, SX, concentrate, after the drying intermediate product (4 S, 5 R)-half methyl esters;
(3), (3a S, 6a RThe preparation of)-vitamin H asymmetric lactone
The intermediate product (4 of step (2) gained S, 5 R)-half methyl esters carries out reduction reaction with borane reducing agent sodium hydride or POTASSIUM BOROHYDRIDE 97MIN again in absolute ethyl alcohol, the gained reduzate through lactonize, precipitate and drying after finally obtain (the 3a of high-optical-purity S, 6a R)-vitamin H asymmetric lactone.
2. a kind of microbial enzyme manufactured (3a as claimed in claim 1 S, 6a RThe method of)-lactone is characterized in that the production of the esterase described in the step (1):
Be about to get 4 ℃ of preservations chocolate microbacterium ( Microbacterium chocolatum) SIT101 CGMCC NO.4436 inclined-plane seed is inoculated in the fermention medium, under 30 ℃, 48h is cultivated in the 160rpm jolting, with 10000 gCentrifugal 15min promptly obtain containing said esterase chocolate microbacterium ( Microbacterium chocolatum) the SIT101 resting cell.
3. a kind of microbial enzyme manufactured (3a as claimed in claim 2 S, 6a RThe method of)-lactone, its spy
Levying fermention medium used in the production process that is the esterase described in the step (1) is glucose 15.0g/L, yeast extract paste 5.0g/L, peptone 10.0g/L, MgSO 41g/L, pH7.0.
4. like claim 1,2 or 3 described a kind of microbial enzyme manufactured (3a S, 6a RThe method of)-lactone,
It is characterized in that (4 described in the step (2) S, 5 RThe preparation of)-half methyl esters:
Be about to contain esterase chocolate microbacterium ( Microbacterium chocolatum) the SIT101 resting cell, being suspended in concentration is 0.1M, in the sodium phosphate salt buffered soln of pH8.0, adds meso dimethyl ester and DMSO 99.8MIN., gets reaction mixture; Again with the reaction mixture of gained behind jolting reaction 48h on 30 ℃, the constant temperature shaking table of 160r/min, use the ethyl acetate extraction acidizing fluid, organic phase with anhydrous sodium sulfate drying afterwards evaporated under reduced pressure obtain (4 S, 5 R)-half methyl esters.
5. a kind of microbial enzyme manufactured (3a as claimed in claim 4 S, 6a RThe method of)-lactone is characterized in that (4 described in the step (2) S, 5 RContain in the reaction mixture described in the preparation process of)-half methyl esters esterase chocolate microbacterium ( Microbacterium chocolatum) weight in wet base of SIT101 resting cell is 70g/L, meso dimethyl ester concentration is 10 ~ 20g/L, the content of DMSO 99.8MIN. is 5% (V/V) in the damping fluid.
6. a kind of microbial enzyme manufactured (3a as claimed in claim 5 S, 6a RThe method of)-lactone is characterized in that the described (3a of step (3) S, 6a RThe preparation of)-vitamin H asymmetric lactone:
Be under the condition of ice bath, with (4 of Calcium Chloride Powder Anhydrous and gained S, 5 R)-half methyl esters is dissolved in the absolute ethyl alcohol, adds borane reducing agent sodium hydride or POTASSIUM BOROHYDRIDE 97MIN, then under the room temperature behind the stirring reaction 18-30h; Add hydrochloric acid soln and carry out lactonization reaction, add zero(ppm) water behind the lactonization reaction again, ice bath cooling deposition; Filter back gained filter cake through vacuum-drying, promptly get (3a S, 6a R)-vitamin H asymmetric lactone.
7. a kind of microbial enzyme manufactured (3a as claimed in claim 6 S, 6a RThe method of)-lactone is characterized in that the described (3a of step (3) S, 6a RIn the preparation process of)-vitamin H asymmetric lactone (4 S, 5 RThe proportioning of)-half methyl esters, Calcium Chloride Powder Anhydrous, reductive agent and absolute ethyl alcohol is calculated by the mole volume ratio, and promptly (4 S, 5 R)-half methyl esters: Calcium Chloride Powder Anhydrous: reductive agent: absolute ethyl alcohol is 1mol:1mol:3mol:4 ~ 5L.
CN201110370466.7A 2011-11-21 2011-11-21 Preparation method for (3aS, 6aR)-biotin chiral lactone Active CN102409068B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110370466.7A CN102409068B (en) 2011-11-21 2011-11-21 Preparation method for (3aS, 6aR)-biotin chiral lactone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110370466.7A CN102409068B (en) 2011-11-21 2011-11-21 Preparation method for (3aS, 6aR)-biotin chiral lactone

Publications (2)

Publication Number Publication Date
CN102409068A true CN102409068A (en) 2012-04-11
CN102409068B CN102409068B (en) 2014-03-26

Family

ID=45911407

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110370466.7A Active CN102409068B (en) 2011-11-21 2011-11-21 Preparation method for (3aS, 6aR)-biotin chiral lactone

Country Status (1)

Country Link
CN (1) CN102409068B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103409478A (en) * 2013-06-21 2013-11-27 浙江圣达药业有限公司 Method for synthesizing biotin intermediate lactone through chemical enzyme method
CN107686488A (en) * 2016-08-05 2018-02-13 浙江医药股份有限公司新昌制药厂 A kind of synthetic method of biotin intermediate

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101284837A (en) * 2008-06-05 2008-10-15 复旦大学 Stereoselective Total Synthesis of (+)-Biotin
CN102120977A (en) * 2010-12-24 2011-07-13 上海应用技术学院 Microbacterium chocolatum and method for preparing (4S,5R)-half ester by using same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101284837A (en) * 2008-06-05 2008-10-15 复旦大学 Stereoselective Total Synthesis of (+)-Biotin
CN102120977A (en) * 2010-12-24 2011-07-13 上海应用技术学院 Microbacterium chocolatum and method for preparing (4S,5R)-half ester by using same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
夏仕文等: "酶在光学活性药物合成中的应用", 《合成化学》 *
陈芬儿等: "d-生物素的不对称全合成研究(Ⅴ)", 《高等学校化学学报》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103409478A (en) * 2013-06-21 2013-11-27 浙江圣达药业有限公司 Method for synthesizing biotin intermediate lactone through chemical enzyme method
CN103409478B (en) * 2013-06-21 2015-01-28 浙江圣达药业有限公司 Method for synthesizing biotin intermediate lactone through chemical enzyme method
CN107686488A (en) * 2016-08-05 2018-02-13 浙江医药股份有限公司新昌制药厂 A kind of synthetic method of biotin intermediate

Also Published As

Publication number Publication date
CN102409068B (en) 2014-03-26

Similar Documents

Publication Publication Date Title
CN112368262B (en) Method for preparing pregabalin intermediate (R) -3- (carbamoylmethyl) -5-methylhexanoic acid
Tamborini et al. Biotransformation with whole microbial systems in a continuous flow reactor: resolution of (RS)-flurbiprofen using Aspergillus oryzae by direct esterification with ethanol in organic solvent
CN103243134A (en) Fermentation production method based on epothilone B metabolic pathways
CN102719378B (en) Method for preparing (-) gamma-lactam by catalysis asymmetry of microorganism
CN102409068B (en) Preparation method for (3aS, 6aR)-biotin chiral lactone
CN102120977B (en) Microbacterium chocolatum and method for preparing (4S,5R)-half ester by using same
CN100489085C (en) Red yeast cell and method of producing optically pure chiral tertiary alcohol
CN105567584B (en) A kind of (+/-) gamma-lactam that can split obtains bacillus and its screening and application of (+) gamma-lactam
CN104651425B (en) A kind of method of living things catalysis synthesizing optical active al lactone
CN101205548A (en) Application of Saccharomyces cerevisiae in the preparation of (S)-(-)-3-chloro-1-phenylpropanol
CN101709322A (en) Method for synthesizing betulic acid by carrying out biocatalysis on betulin
CN108410749B (en) Method for preparing (-)γ-lactam by asymmetric hydrolysis of marine low temperature (+)γ-lactamase
CN102465159B (en) Synthesis process for preparing eslicarbazepine with microbial method
CN101864370B (en) Yeast strain converting quinuclidone into R-3-quinuclidinol and conversion method thereof
CN101824438B (en) Method for preparing (S)-3-hydroxy butyric acid ethyl ester through ethyl acetoacetate microbial conversion
CN105586289B (en) A kind of (+/-) gamma-lactam that can split obtains pseudomonad and its screening and application of (-) gamma-lactam
CN103589665A (en) Rhodococcus qingshengii and application thereof in preparation of ethyl (S)-4-chloro-3-hydroxy butyrate
CN103114122A (en) Method for preparing trans-4-aminomethyl-naphthenic acid from Actioplanes sp.
CN102925500A (en) Preparation method of chiral 4-hydroxy-4 phenyl butyric acid ester
CN102925368B (en) Beauveria bassiana capable of catalyzing an asymmetric reduction reaction and its application
CN101186938B (en) A kind of preparation method of D-biotin intermediate lactone
CN106086090A (en) A kind of method that two-step microbial conversion method prepares R mandelic acid
CN1778889A (en) Bacteria and method for preparing (S)-4-chloro-3-hydroxybutyrate by biocatalysis
Zheng et al. Chemoenzymatic synthesis of d-biotin intermediate lactone via lipase-catalyzed desymmetrization of meso diols
CN102719497B (en) Method for preparing methyl (S)-(+)-mandelate by microbial transformation of methyl benzoylformate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: ZHENGJIANG SHENGDA BIO-PHARMACEUTICAL CO., LTD.

Free format text: FORMER NAME: ZHEJIANG SHENGDA PHARMACEUTICAL CO., LTD.

CP03 Change of name, title or address

Address after: 317200 No. 789, Renmin East Road, Chicheng street, Tiantai County, Zhejiang

Patentee after: ZHEJIANG SHENGDA BIO-PHARM CO., LTD.

Patentee after: Shanghai Institute of Technology

Address before: 317200, Zhejiang City, Taizhou province Tiantai Road East Road Extension

Patentee before: Zhejiang Shengda Pharmaceutical Co., Ltd.

Patentee before: Shanghai Institute of Technology